Document is current

Article History

Received: 8 September 2023

Accepted: 11 December 2023

First Online: 24 January 2024

Declarations

:

: LL has served on the advisory boards for: Lilly, Exact Sciences, AstraZeneca, Italfarmaco and Daiichi Sankyo; has received consulting fee from: Exact Sciences, Helsinn and Eisai; honoraria for speakers’ bureaus from: Gilead and Exact Sciences; support for travel, accommodations, expenses from: Lilly and Gilead. RDS has served on the advisory boards for: Novartis, Lilly, Istituto Clinico Gentili, Ipsen, Amgen, EISAI. AV reports honoraria from Roche and Lilly ELS has received consulting fee and served on the advisory boards for: Exact Sciences, Seagen. EM has received consulting fee and served on the advisory boards for: Exact Sciences, EISAI, MSD Oncology, Daiichi Sankyo/Astra Zeneca, Pfizer, Seagen; support for travel, accommodations, expenses from: Roche, Pfizer, Lilly, Novartis. EGR has received advisory fee from AstraZeneca, Exact Sciences, GSK, Novartis, Roche; honoraria from AstraZeneca, GSK, Novartis, Thermo Fisher Scientific; travel accommodation and expenses from AstraZeneca, GSK, LCM Genect, Novartis, Roche, Thermo Fisher Scientific; grants and non-financial support from Thermo Fisher Scientific, Roche. CT has received consulting fee and served on the advisory boards for: Myriad Genetics, MSD Oncology and Amgen; honoraria for speakers’ bureaus from: Amgen; support for travel, accommodations, expenses from: Takeda, Amgen, MSD, Eli Lilly Italia SPA, Roche, Pfizer. AZ has received personal fees and non-financial support from Novartis, AstraZeneca, Lilly, Pfizer, Daiichi Sankyo, MDS (Merck Sharp&Dome), Roche, Seagen, Exact Sciences, Gilaed, Istituto Gentili. GP has served on the advisory boards for: ADS Biotec; has received honoraria for speakers’ bureaus and travel funding from: Lilly, AstraZeneca, Exact Sciences, Novartis. GB has received consulting fee from Roche, AstraZeneca, Novartis, MSD, Sanofi, Daiichi Sankyo, and Exact Sciences; honoraria for speakers’ bureaus from Roche, Pfizer, Astra- Zeneca, Lilly, Novartis, Neopharm Israel, MSD, Chugai, Daiichi Sankyo, EISAI, and Exact Sciences; support for travel, accommodations, expenses from Roche, Pfizer, and AstraZeneca; is co-inventor of ‘European patent Application N. 12195182.6 and 12196177.5 titled “PDL-1 expression in anti-HER2 therapy” -Roche- Issued (no compensation provided); and has served on the advisory boards for Roche, Pfizer, Daiichi Sankyo, Lilly, MSD, Novartis, AstraZeneca, Genomic Health, EISAI, Gilead, and Seagen.